Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details)

v2.4.0.6
Commitments and Contingencies (Details) (USD $)
6 Months Ended
Jun. 30, 2012
Commitments and Contingencies (Textual) [Abstract]  
Contingent consideration for future consideration 20,100,000
Accrued expenses 5,200,000
Other long-term liabilities 14,900,000
CURNA Acquisition [Member]
 
Commitments and Contingencies (Textual) [Abstract]  
Contingent consideration for future consideration 20,100,000
Vidus Ocular Inc. Acquisition [Member]
 
Commitments and Contingencies (Textual) [Abstract]  
Additional shares to be issued if stock price is not at specified price 413,850
Vidus Ocular Inc. Acquisition [Member] | Milestone Shares [Member]
 
Commitments and Contingencies (Textual) [Abstract]  
Agreement to purchase securities with Vidus 488,420